Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Section Editors
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
INVITED EDITORIAL
Cardiovascular disease in cancer patients: a neglected dimension of modern oncology
1
Prevention of Metabolic Disorders Research Center, Research Institute for Metabolic and Obesity Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2
Faculty of Medicine, John Paul II Catholic University of Lublin (KUL), Lublin, Poland
3
Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland
Submission date: 2026-04-28
Acceptance date: 2026-04-30
Online publication date: 2026-04-30
Corresponding author
Maciej Banach
Faculty of Medicine John Paul II Catholic University of Lublin (KUL) Lublin, Poland Department of Preventive Cardiology and Lipidology Medical University of Lodz (MUL), Poland
Faculty of Medicine John Paul II Catholic University of Lublin (KUL) Lublin, Poland Department of Preventive Cardiology and Lipidology Medical University of Lodz (MUL), Poland
Arch Med Sci 2026;22(2):782-784
TOPICS
REFERENCES (17)
1.
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74: 229-63.
2.
Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators. Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023. J Am Coll Cardiol 2025; 86: 2167-43.
3.
Alhuneafat L, Guha A, Blaes A, Konety SH. Cancer and cardiovascular disease: shared risk factors, mechanisms, and clinical implications: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol 2025; 7: 453-69.
4.
Gao S, Zhu H, Chang X, et al. Cardiovascular death risk in patients with solid tumors: a population-based study in the United States. Eur J Cancer Prev 2025; 34: 11-23.
5.
Styczkiewicz K, Lewicka E, Bielecka-Dąbrowa A, et al. Principles of primary prevention of cardiovascular diseases in patients with cancer. Expert Opinion of the Working Group on Prevention and Epidemiology (Cardio-oncology Task Force) and the Working Group on Cardio-oncology of the Polish Cardiac Society. Pol Heart J 2026; 84: 131-56.
6.
Zullig LL, Sung AD, Khouri MG, et al. Cardiometabolic comorbidities in cancer survivors: JACC: CardioOncology state-of-the-art review. JACC CardioOncol 2022; 4: 149-65.
7.
Dyrbuś K, Banach M, Gil R, et al. Interdisciplinary expert team statement on the treatment of multi-bed atherosclerotic disease – endorsed by Polish Cardiac Society, Polish Lipid Association, Polish Society of Diabetology, Polish Neurological Society, Polish Society of Nephrology. Pol Heart J 2025; 83: 531-9.
8.
Viñas-Mendieta AE, Gallardo-Grajeda A, López-Fernández T. Cardio-oncology: chances and challenges. Basic Res Cardiol 2025; 120: 3-9.
9.
Qiu X, Hu B, Ke J, Gu J. Global co-occurrence patterns of cancer and cardiovascular disease: a comprehensive analysis based on the Global Burden of Disease Study 2021. Arch Med Sci 2026; 22: 760-81.
10.
Ahmad J, Muthyala A, Kumar A, Dani SS, Ganatra S. Disparities in cardio-oncology: effects on outcomes and opportunities for improvement. Curr Cardiol Rep 2022; 24: 1117-27.
11.
Banach M, Mastalerz-Migas A, Wita K, Myśliwiec M. Poland takes a lead in effective lipid disorders management healthcare programmes in Europe. Am J Prev Cardiol 2025; 24: 101346.
12.
Ganjali S, Banach M, Pirro M, Fras Z, Sahebkar A. HDL and cancer-causality still needs to be confirmed? Update 2020. Semin Cancer Biol 2021; 73: 169-77.
13.
Freihat O, Sipos D, Aamir M, Kovacs A. Global burden and future projections of non-communicable diseases (2000–2050): progress toward SDG 3.4 and disparities across regions and risk factors. PLoS One 2025; 20: e0336036.
14.
Banach M. No time to wait: daily step counts should be incorporated into physical activity guidelines. Arch Med Sci 2025; 21: 2164-7.
15.
Banach M, Fogacci F, Atanasov AG, et al. A 360 perspective on cardiovascular prevention: the International Lipid Expert Panel SiMple tIps for the heaLthy hEart (ILEP-SMILE). Arch Med Sci 2025; 21: 711-8.
16.
Ding D, Nguyen B, Nau T, et al. Daily steps and health outcomes in adults: a systematic review and dose-response meta-analysis. Lancet Public Health 2025; 10: e668-81.
17.
TamehriZadeh SS, Khalaji M, Tajdari M, et al. Statins: novel approaches for the management of doxorubicin-induced cardiotoxicity – a literature review. Cardiovasc Toxicol 2025; 25: 1429-52.
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
